INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2012

Caffeine did not reduce daytime sleepiness but improved motor scores in Parkinson disease.

Sixty-one patients with Parkinson disease and daytime somnolence were randomized to caffeine (up to 200 mg twice daily) or placebo for six weeks. Intention-to-treat analysis showed a nonsignificant change in Epworth Sleepiness Scale score (-1.71 points; 95% CI -3.57, 0.13). However, caffeine lowered the overall score on the Unified Parkinson's Disease Rating Scale (-4.69 points; 95% CI -7.7, -1.6) and its objective motor rating (-3.15 points; 95% CI -5.50, -0.83).

Study type
Randomized controlled trial
Who was studied
61 patients with Parkinson disease and daytime somnolence
What was measured
Daytime somnolence and motor severity

THE PAPER

Caffeine for treatment of Parkinson disease: a randomized controlled trial.

Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, Filla L, Zanatta D, Rios Romenets S, Altman R, Chuang R, Shah B. Neurology, 2012.

PubMed 22855866 ↗DOI 10.1212/WNL.0b013e318263570d ↗

Brain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.